Rutabaga Capital Management LLC MA acquired a new position in shares of RTI Surgical, Inc. (NASDAQ:RTIX) in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor acquired 844,346 shares of the medical equipment provider’s stock, valued at approximately $4,939,000. Rutabaga Capital Management LLC MA owned approximately 1.43% of RTI Surgical as of its most recent filing with the SEC.
Other large investors have also added to or reduced their stakes in the company. Cigna Investments Inc. New acquired a new position in shares of RTI Surgical during the 2nd quarter worth about $105,000. Citigroup Inc. boosted its position in shares of RTI Surgical by 2,850.1% during the 2nd quarter. Citigroup Inc. now owns 21,152 shares of the medical equipment provider’s stock worth $124,000 after acquiring an additional 20,435 shares in the last quarter. First Quadrant L P CA acquired a new position in shares of RTI Surgical during the 2nd quarter worth about $137,000. American International Group Inc. boosted its position in shares of RTI Surgical by 7.0% during the 1st quarter. American International Group Inc. now owns 35,371 shares of the medical equipment provider’s stock worth $141,000 after acquiring an additional 2,327 shares in the last quarter. Finally, Thompson Davis & CO. Inc. boosted its position in shares of RTI Surgical by 138.8% during the 2nd quarter. Thompson Davis & CO. Inc. now owns 25,077 shares of the medical equipment provider’s stock worth $147,000 after acquiring an additional 14,577 shares in the last quarter. 69.99% of the stock is owned by institutional investors and hedge funds.
COPYRIGHT VIOLATION NOTICE: “844,346 Shares in RTI Surgical, Inc. (RTIX) Acquired by Rutabaga Capital Management LLC MA” was first posted by TrueBlueTribune and is owned by of TrueBlueTribune. If you are accessing this news story on another website, it was illegally copied and republished in violation of US and international copyright legislation. The correct version of this news story can be viewed at https://www.truebluetribune.com/2017/10/13/844346-shares-in-rti-surgical-inc-rtix-acquired-by-rutabaga-capital-management-llc-ma.html.
Several research analysts have recently issued reports on RTIX shares. BidaskClub cut RTI Surgical from a “strong-buy” rating to a “buy” rating in a research report on Tuesday, July 25th. Zacks Investment Research cut RTI Surgical from a “hold” rating to a “sell” rating in a research report on Thursday, October 5th.
RTI Surgical, Inc. (RTIX) traded down 2.06% on Friday, hitting $4.75. The stock had a trading volume of 21,444 shares. The stock’s market cap is $280.41 million. RTI Surgical, Inc. has a one year low of $2.50 and a one year high of $6.00. The company’s 50-day moving average is $4.59 and its 200-day moving average is $4.84.
RTI Surgical (NASDAQ:RTIX) last posted its quarterly earnings results on Tuesday, August 8th. The medical equipment provider reported $0.02 EPS for the quarter, hitting the Zacks’ consensus estimate of $0.02. The business had revenue of $72.10 million during the quarter, compared to the consensus estimate of $70.25 million. RTI Surgical had a positive return on equity of 2.07% and a negative net margin of 6.53%. RTI Surgical’s revenue for the quarter was up 6.7% compared to the same quarter last year. On average, analysts anticipate that RTI Surgical, Inc. will post $0.06 earnings per share for the current fiscal year.
In other news, EVP John N. Varela purchased 12,000 shares of the firm’s stock in a transaction that occurred on Friday, August 11th. The stock was acquired at an average cost of $4.85 per share, for a total transaction of $58,200.00. Following the completion of the purchase, the executive vice president now owns 47,998 shares of the company’s stock, valued at $232,790.30. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Nicholas J. Valeriani purchased 5,500 shares of the firm’s stock in a transaction that occurred on Monday, August 21st. The stock was purchased at an average price of $4.70 per share, with a total value of $25,850.00. Following the completion of the purchase, the director now directly owns 47,754 shares of the company’s stock, valued at approximately $224,443.80. The disclosure for this purchase can be found here. 4.90% of the stock is currently owned by company insiders.
RTI Surgical Company Profile
RTI Surgical, Inc is engaged in producing orthopedic and other surgical implants that repair and promote the natural healing of human bone and other human tissues. The Company uses natural tissues, metals and synthetics process to produce its products. The Company’s business primarily consists of six categories, such as spine, sports medicine, ortho fixation, bone graft substitutes and general orthopedic (BGS and general orthopedic), dental and surgical specialties.
Receive News & Ratings for RTI Surgical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RTI Surgical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.